Attached files

file filename
EX-31.1 - EX-31.1 - Lipocine Inc.d614851dex311.htm
EXCEL - IDEA: XBRL DOCUMENT - Lipocine Inc.Financial_Report.xls
EX-31.2 - EX-31.2 - Lipocine Inc.d614851dex312.htm
10-Q - 10-Q - Lipocine Inc.d614851d10q.htm
EX-32.2 - EX-32.2 - Lipocine Inc.d614851dex322.htm

EXHIBIT 32.1

CERTIFICATION

In connection with the Quarterly Report on Form 10-Q of Lipocine Inc. (the “Corporation”) for the quarter ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Mahesh V. Patel, President and Chief Executive Officer of the Corporation, hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(d) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

 

Dated: November 12, 2013

     

/s/ Mahesh V. Patel

     

Mahesh V. Patel, President and Chief Executive Officer

(Principal Executive Officer)

“This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.”